Financial toxicity: An adverse effect worthy of a black box warning?
作者信息
Dottino Joseph A, Rauh-Hain J Alejandro
机构信息
Departments of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.
Departments of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX; Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, TX.
出版信息
Gynecol Oncol. 2020 Feb;156(2):263-264. doi: 10.1016/j.ygyno.2020.01.016.
Abstract
摘要
相似文献
1
Financial toxicity: An adverse effect worthy of a black box warning?
Gynecol Oncol. 2020 Feb;156(2):263-264. doi: 10.1016/j.ygyno.2020.01.016.
2
Teens and indoor tanning: time to act on the US Food and Drug Administration's black-box warning.
Ann Surg Oncol. 2015 Mar;22(3):701-3. doi: 10.1245/s10434-014-4257-6. Epub 2014 Dec 17.
3
Common Insomnia Drugs Receive Black Box Warning.
Am J Nurs. 2019 Aug;119(8):22. doi: 10.1097/01.NAJ.0000577420.37447.fd.
4
Timing of new black box warnings and withdrawals for prescription medications.
JAMA. 2002 May 1;287(17):2215-20. doi: 10.1001/jama.287.17.2215.
5
Content, Consistency, and Quality of Black Box Warnings: Time for a Change.
Ann Intern Med. 2015 Dec 1;163(11):875-6. doi: 10.7326/M15-1097. Epub 2015 Sep 29.
6
US Food and Drug Administration Black Box Warnings.
J Am Podiatr Med Assoc. 2020 Jan;110(1):Article10. doi: 10.7547/18-064.
7
New and incremental FDA black box warnings from 2008 to 2015.
Expert Opin Drug Saf. 2018 Feb;17(2):117-123. doi: 10.1080/14740338.2018.1415323. Epub 2017 Dec 17.
8
Content, Consistency, and Quality of Black Box Warnings.
Ann Intern Med. 2016 Jul 5;165(1):74-5. doi: 10.7326/L16-0071.
9
The FDA Revises Boxed Warning For Fluoroquinolones-Again.
Am J Nurs. 2016 Sep;116(9):22-3. doi: 10.1097/01.NAJ.0000494691.55746.90.
10
Boxed Warning Removed from Canagliflozin Labeling.
Am J Nurs. 2020 Dec;120(12):22. doi: 10.1097/01.NAJ.0000724216.07917.8f.
本文引用的文献
1
Extensive financial hardship among gynecologic cancer patients starting a new line of therapy.
Gynecol Oncol. 2020 Feb;156(2):271-277. doi: 10.1016/j.ygyno.2019.11.022. Epub 2019 Nov 23.
2
Financial Burdens of Cancer Treatment: A Systematic Review of Risk Factors and Outcomes.
J Natl Compr Canc Netw. 2019 Oct 1;17(10):1184-1192. doi: 10.6004/jnccn.2019.7305.
3
Financial Toxicity: A Severe But Underrecognized Side Effect for Cancer Patients.
Gynecol Oncol. 2019 Jul;154(1):1-2. doi: 10.1016/j.ygyno.2019.06.005.
4
Financial toxicity in gynecologic oncology.
Gynecol Oncol. 2019 Jul;154(1):8-12. doi: 10.1016/j.ygyno.2019.04.003. Epub 2019 Apr 30.
5
Financial Toxicity in Advanced and Metastatic Cancer: Overburdened and Underprepared.
J Oncol Pract. 2019 Apr;15(4):e300-e307. doi: 10.1200/JOP.18.00518. Epub 2019 Mar 7.
6
Financial toxicity - An overlooked side effect.
Gynecol Oncol. 2018 Jul;150(1):3-6. doi: 10.1016/j.ygyno.2018.05.012. Epub 2018 May 31.
7
Financial Hardships Experienced by Cancer Survivors: A Systematic Review.
J Natl Cancer Inst. 2016 Oct 20;109(2). doi: 10.1093/jnci/djw205. Print 2017 Feb.
8
The High Cost of Prescription Drugs in the United States: Origins and Prospects for Reform.
JAMA. 2016;316(8):858-71. doi: 10.1001/jama.2016.11237.
9
Association of Financial Strain With Symptom Burden and Quality of Life for Patients With Lung or Colorectal Cancer.
J Clin Oncol. 2016 May 20;34(15):1732-40. doi: 10.1200/JCO.2015.63.2232. Epub 2016 Feb 29.
10
Population-based assessment of cancer survivors' financial burden and quality of life: a prospective cohort study.
J Oncol Pract. 2015 Mar;11(2):145-50. doi: 10.1200/JOP.2014.001542. Epub 2014 Dec 16.
Zotero 插件